The U.S. Food and Drug Administration has granted fast track designation for a Framingham company to begin expanded clinical trials of an Alzheimer's drug.
The president of the College of the Holy Cross has set up a commission to collect input on whether the school should drop its Crusader name and mascot.
A California biopharmaceutical company said Monday it is distributing $7.5 million to support five HIV cure research initiatives, including at UMass Medical School.